New option listings for April 6th include enGene Holdings Inc (ENGN), Keel Infrastructure Corp. (KEEL), and NovaBay Pharmaceuticals Inc (SDEV). Option delistings effective April 6th include NovaBay (NBY), Bitfarms (BITF), and The Brand House Collective, Inc. (TBHC).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN:
- 3 Best Stocks to Buy amid the Market Pullback, According to Top Analysts
- enGene price target lowered to $9 from $10 at UBS
- enGene price target lowered to $30 from $33 at Oppenheimer
- enGene price target lowered to $27 from $30 at Guggenheim
- Buy Rating on enGene: Detalimogene’s Competitive Efficacy, Community-Friendly Delivery, and Regulatory Momentum Support $25 Target